FDA announcement regarding termination of primate study leaves many questions unanswered

On Friday, January 26, the US Food and Drug Administration (FDA)—the agency charged with protecting public health via oversight of food, drugs, and medical devices—issued a statement about its decision to terminate a nicotine research project at the National Center for Toxicology Research (NCTR). The research had been the focus of campaign by an anti-animal … Continue reading FDA announcement regarding termination of primate study leaves many questions unanswered

The Curious Case of Catheter Removals at the FDA

The FDA Commissioner, Scott Gottlieb, made a statement last week that claimed animal welfare concerns had led to his agency’s decision to end a primate research project aimed at better understanding nicotine addiction in adolescents. However, details revealed in the project documents that were also released by the agency last week raise doubts about the … Continue reading The Curious Case of Catheter Removals at the FDA

Response to FDA statement on termination of a primate nicotine research study

The US Food and Drug Administration (FDA)  announced yesterday that it terminated a study investigating the effects of nicotine in monkeys.  This announcement, which was accompanied by the release of many records and documents related to the animals’ care, is troubling for many reasons.  Among them, it again raises questions about oversight and decision-making. Nicotine … Continue reading Response to FDA statement on termination of a primate nicotine research study